MEDPACE CLINICAL RESEARCH INDIA PRIVATE LIMITED

During the FY19-20, the Indian arm of the US-based clinical research organisation generated a revenue figure of Rs 5 crore, exhibiting growth of 25 per cent in its business when compared to the revenue generation of Rs 4 crore in the previous fiscal. Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.